More tools:Markets·Screener·Research·Chat

RxSight, Inc. Common Stock (RXST) Financial Statements

RxSight, Inc. Common Stock
SIC 3851 · OPHTHALMIC GOODS
FIGI BBG00THX1YQ1
XNAS · usd
6.45▲ 0.00 (0.00%)
As of 2026-09-09
Valuation
Market Cap
Enterprise Value
Trailing P/E—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close6.45
Day's Range6.05 – 6.47
52-Week Range4.48 – 13.22
Volume733.0K
Avg Volume843.5K
Share Statistics
Shares Outstanding
Employees461
ExchangeXNAS
Listed2021-07-30
Share count as of July 31, 2026
Loading Income Statement…
Key questions about RxSight, Inc. Common Stock (RXST)
What is RxSight, Inc. Common Stock's Market Cap?
RxSight, Inc. Common Stock's Market Cap is $268.3M, based on as-reported figures from SEC (XBRL) filings.
What is RxSight, Inc. Common Stock's Enterprise Value?
RxSight, Inc. Common Stock's Enterprise Value is $59.6M, based on as-reported figures from SEC (XBRL) filings.
What is RxSight, Inc. Common Stock's Price / Sales?
RxSight, Inc. Common Stock's Price / Sales is 2.2×, based on as-reported figures from SEC (XBRL) filings.
What is RxSight, Inc. Common Stock's EV / Revenue?
RxSight, Inc. Common Stock's EV / Revenue is 0.5×, based on as-reported figures from SEC (XBRL) filings.
What is RxSight, Inc. Common Stock's EV / EBITDA?
RxSight, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is RxSight, Inc. Common Stock's Revenue (TTM)?
RxSight, Inc. Common Stock's Revenue (TTM) is $121.1M, based on as-reported figures from SEC (XBRL) filings.
What is RxSight, Inc. Common Stock's Net Income (TTM)?
RxSight, Inc. Common Stock's Net Income (TTM) is -$46.9M, based on as-reported figures from SEC (XBRL) filings.
What is RxSight, Inc. Common Stock's EBITDA?
RxSight, Inc. Common Stock's EBITDA is -$51.6M, based on as-reported figures from SEC (XBRL) filings.
What is RxSight, Inc. Common Stock's Diluted EPS (TTM)?
RxSight, Inc. Common Stock's Diluted EPS (TTM) is -1.13, based on as-reported figures from SEC (XBRL) filings.
What is RxSight, Inc. Common Stock's EBITDA Margin?
RxSight, Inc. Common Stock's EBITDA Margin is -42.6%, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenue:
Total revenues———
YoY growth+0.3%———
Costs and expenses:
Cost of sales
Selling, general and administrative
Research and development
Total costs and expenses———
Loss from operations
% of revenue-40.8%———
Other income (expense), net:
Interest expense
Interest and other income
Loss on extinguishment of term loan————
Loss before income taxes
Income tax expense
Net loss
% of revenue-35.9%———
Basic net loss per share
Diluted net loss per share